News - UF Innovate

Two-Year Backlog in Biologicals Manufacturing Hinders Medical R&D, Development of New Therapies for COVID-19

One area where COVID-19 has had a substantial impact is the development and manufacturing of medicines, medical devices, and pharmaceutical products. The CDMO industry is showing enormous growth and is projected to become a $315 billion industry by 2026. However, the demand for products skyrocketed so quickly that supply has not been able to keep pace. According to Dr. Ian White, president and CSO of Neobiosis, a UF Innovate | Sid Martin Biotech resident company that focuses on the science of regenerative medicine, demand has caused a two-year backlog of desperately needed cellular and acellular products for use in research and clinical trials directed at treating the COVID-19 virus and its complications (AKA Post-COVID Syndrome).

UF Innovate | Incubation Services Resident Signum Biosciences Launches Epicutis, a Professional Luxury Medical-Grade Skincare Line

UF Innovate | Sid Martin Biotech resident Signum Biosciences, a biopharma company with 20 years of topical drug development and skincare ingredient expertise, announced the launch of Epicutis, a new professional, medical-grade luxury skincare line.

Breast Milk of Mothers Who Received COVID-19 Vaccine Contains Antibodies That Fight Illness

The breast milk of lactating mothers vaccinated against COVID-19 contains a significant supply of antibodies that may help protect nursing infants from the illness, according to new research from the University of Florida.

UF Health Team Develops Technique To Conserve Oxygen During Acute Shortages

With the oxygen shortage in mind, a team at the University of Florida Health’s Center for Safety, Simulation and Advanced Learning Technologies, or CSSALT, conceived a novel way to prolong the life of oxygen cylinders by reducing oxygen waste.

Greater Gift, AGTC, and 2020 On-Site Partner To Honor & Celebrate Clinical Trial Participants and Provide Eye Exams to Underserved Children in the Local Community

Greater Gift of Winston Salem, a non-profit that celebrates participation in clinical trials, announced a partnership with UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company developing genetic therapies for the treatment of rare inherited retinal diseases (IRDs), and mobile vision provider 2020 On-site, a company involved in IRD clinical research and provides complimentary eye exams and facilitates the delivery of eyeglasses to students in need.

UF/IFAS Scientist Publishes New Data on Insect Causing Lethal Disease in Palm Trees

A University of Florida scientist has published an in-depth look at the insect responsible for infecting more than a dozen species of palm trees worldwide, including the official state tree, with a deadly disease known as lethal bronzing.

AGTC Announces Sponsorship of Achroma Corp’s No Roadblocks Program

UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare retinal diseases, announced it will be a sponsor of the Achroma Corp program, No Roadblocks.

UF Professor Recognized for a Career of Accomplishment

Fred G. Gmitter, Jr., professor of horticulture and citrus breeder at the University of Florida Institute of Food and Agricultural Sciences Citrus Research and Education Center, has been recognized as a 2021 Fellow by the American Society for Horticultural Science.

New Mouse-Model Research by UF Neuroscientists Provides Fresh Insight Into Parkinson’s Disease

New mouse-model research by University of Florida neuroscientists provides fresh insight into the impact of elevated levels of the protein alpha-synuclein on the function of dopamine-producing nerve cells, the progressive demise of which is associated with Parkinson’s disease.

Cannabix Technologies Granted U.S. Patent for FAIMS Molecular Analysis Device

UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, is pleased to report that the United States Patent and Trademark Office (USPTO) has granted patent No. 17/019728 entitled, “Apparatus and Methods for Detection of Molecules” to the company.

UF News